Andrew Gengos's Net Worth
Andrew Gengos's net worth is estimated to be at least $304,174.16 as of 06/26/2025. CoreStreet's estimation of Andrew Gengos's net worth is based on their sale of stock and current holding of stock.
Andrew Gengos is CFO at Terns Pharmaceuticals Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,000 units of TERN stock on 06/16/2025. Their biggest sale was on 01/05/2024 when they sold 1,208 units of Athira Pharma Inc stock for $3,515.28. They typically trade 2 times per year.
Total value of insider buys:
- $299,933.84
Total value of insider sells:
- $4,240.32
Most recent insider trade:
- June 16, 2025
Andrew Gengos's Insider Trading History
| Terns Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 16, 2025 | CFO | 5,000 | $3.95 | Buy | $19,750.00 |
June 13, 2025 | CFO | 10,000 | $3.73 | Buy | $37,300.00 |
| Athira Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 5, 2024 | CFO | 1,272 | $0.57 | Sell | $725.04 |
Jan. 5, 2024 | Insider | 1,208 | $2.91 | Sell | $3,515.28 |
June 7, 2023 | Insider | 15,000 | $3.43 | Buy | $51,450.00 |
June 5, 2023 | Insider | 45,000 | $3.00 | Buy | $135,000.00 |
June 2, 2023 | Insider | 20,012 | $2.82 | Buy | $56,433.84 |